Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance - Wikidata - wikimedia - TriplyDB

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

http://www.wikidata.org/entity/Q26865927

about

Three-dimensional structures of membrane proteins from genomic sequencing Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections Plasma membrane transporters in modern liver pharmacology Marine natural products as breast cancer resistance protein inhibitors Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma Current advances in biomarkers for targeted therapy in triple-negative breast cancer Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing The reversal effects of 3-bromopyruvate on multidrug resistance in vitro and in vivo derived from human breast MCF-7/ADR cells Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter Breast cancer resistance protein regulates apical ectoplasmic specialization dynamics stage specifically in the rat testis ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cells Architecture of Chimeric Spheroids Controls Drug Transport.G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance.WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.Predicting substrates of the human breast cancer resistance protein using a support vector machine method.Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.Transcriptomic insights on the ABC transporter gene family in the salmon louse Caligus rogercresseyi.Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells.ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer.Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2.BCRP protein levels do not differ regionally in adult human livers, but decline in the elderly.Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity.

P2860

Q24630589-79FEB756-2FA7-44DC-B84C-DD465BD0A415 Q26741846-EB15557B-A08D-4197-BF43-90D92D61372A Q26781386-84610B4C-D24C-4E1E-B568-B63C0407C76B Q26829263-9B25ABFE-3C89-4B95-AD68-2F59AA6C8B98 Q27027706-E9BB7B7A-2CF5-47E5-83D7-564AC27EC347 Q28072875-48BF7B15-9D1B-4044-BF99-C00042A98FE1 Q28074202-329127E1-49B1-4875-80C9-22CB8E06FDA4 Q28393898-580BE198-E9EB-42AE-A4F4-C130BBC98208 Q28535342-3E22ACF4-42DD-4A4C-9969-74E004058767 Q28543003-BF963B57-11BF-4073-AA54-FA4D139BE705 Q28544747-4C75AD3B-1954-4E51-8374-E6B98EF0AF93 Q28552715-9E803F16-3B51-4250-B55F-F609891F011A Q28579813-4EF400B4-5201-4D6D-8B0B-2EFFB398BB21 Q30393893-EF1173C7-F83E-422E-AE27-A06DBA85B930 Q30661839-BA8C642A-FBCD-4511-AAD5-EA27E4C812F2 Q30845910-6FD04C6C-CEFD-4ADC-9285-742734D48D9E Q33623142-C5BBD0B5-6805-4B24-83B2-D30CD1078592 Q33635355-5892A3ED-0F2B-4F27-B093-42BE55967AB7 Q33706574-7BD178EB-D8AC-474C-BC14-D4D181A2884A Q33739392-FFFBDE0E-7099-46E9-8E8B-4CBBB5A0CF37 Q33753279-4ADDAE3A-E5B3-4751-BF38-C010CB6A1FAD Q33763765-61FE311D-6676-400B-9836-A1A07C39D13F Q33827053-B59C6E88-736A-4EE0-AE17-48B93A10F052 Q34668324-D6AE3534-13D5-47B3-BC90-3E6CFEBECC05 Q34871636-29E8C98F-F7C1-4C79-AF62-751CA5CDE1FA Q35108153-E15F42FC-BD22-4BF0-8220-C645CF3164CD Q35494142-17462958-BE26-4F7F-A9F3-A0A8D73952A7 Q35592570-1971B658-DAEA-4D32-9CEB-3A75D8194BF9 Q35890322-C47D3CE4-79CF-48BE-8D60-6194A817F501 Q35927508-2F12D795-7782-4B8B-B603-A3EB0BB410EE Q35936477-EDB5A9CC-BE54-4860-B823-43485A769CC9 Q35964440-1D580F99-D4D3-430F-A765-0C3EA7BF5CE2 Q36030787-43B399CC-F2A3-4506-9D19-7BE6955C6360 Q36041530-DE4A58CD-AAC7-4F2A-B78A-5E3AB506D6E9 Q36186168-AC0936CE-AD37-41EA-9E12-56AB6997C8F2 Q36335981-40E96110-377A-4781-9116-6B498724B965 Q36414807-102A0ADF-EAF8-4C69-8E6C-98D5841ECFAA Q36618624-51E22096-47AA-4622-8384-7CE2087010F8 Q36629578-F5B33F20-7110-484C-87E2-3369C901189F Q36767061-61B8CCA7-714F-44F5-8151-9A7950A60D29

P2860

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

http://www.wikidata.org/entity/Q26865927

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@ast

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@en

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@nl

type

label

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@ast

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@en

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@nl

prefLabel

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@ast

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@en

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@nl

P1433

Q26865927-C3467443-7498-431C-9221-E9544D94B81B

P1476

Q26865927-46D91B06-C1B0-4A3F-BD80-335EF6C7069F

P2093

Q26865927-09ECE72A-5760-48B7-B37D-5F1D31C6EE0C

Q26865927-77BE723E-78F1-4A76-90BF-82991B0050D3

Q26865927-828B1C79-D4B7-4518-B58B-40E03D5BBB36

Q26865927-BE2FBF43-C9CC-435F-A1E8-8F6BEA163087

P2860

Q26865927-00AB497B-E37B-420A-87E1-F29A850E9567

Q26865927-00F70351-F71F-4649-9418-9B4288DB758C

Q26865927-02EF08C7-BB30-43D6-9DEC-45AAE4991EE5

Q26865927-034DB33C-902C-4646-B683-CB249A6AADF6

Q26865927-040F371E-3ADA-4BB5-B6C6-EEA99903C089

Q26865927-04C1BCC1-439C-473E-A7EC-C1201654C475

Q26865927-0636D1F4-7496-4F06-9DD6-9DF120451EC6

Q26865927-0654A05F-60EF-467E-8E2C-342C28A06E23

Q26865927-0711DA1D-CDA0-45D3-980F-326200D1F4E3

Q26865927-07A9D5B0-20CE-4579-B18A-22842D879BB8

P304

Q26865927-D2B5CB7F-191B-4347-8C5B-5682B56AE3FC

P31

Q26865927-A673189D-094D-4929-B01C-E2630B17BA76

P3181

Q26865927-6DC457CD-1721-4DCA-B9B0-EF368DCA7193

P356

Q26865927-65E176EB-F292-451C-B0FD-BFBE6B3FD3E8

P407

Q26865927-A2F2B66D-6CD2-40A5-87E4-F14F07374256

P433

Q26865927-582C214B-F76E-454A-A544-84B9F9B1A1CC

P478

Q26865927-6D9DA691-8A36-4572-AB80-6C7ED0185AAD

P577

Q26865927-F9E1BDA0-4F9D-4104-8621-E0B493715271

P5875

Q26865927-1F0BDEEC-BC7A-46EB-AC50-BB52FA581F0C

P698

Q26865927-DEEE3B24-47F9-4BA9-AA8D-264FDC2D2B8E

P932

Q26865927-2C305393-0EC3-4628-985E-5E953B93E61A

P3181

P356

J.BCP.2012.01.002

P1433

Biochemical Pharmacology

P1476

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

@en

P2093

Douglas D. Ross

http://www.w3.org/2001/XMLSchema#string

Karthika Natarajan

http://www.w3.org/2001/XMLSchema#string

Maria R. Baer

http://www.w3.org/2001/XMLSchema#string

Yi Xie

http://www.w3.org/2001/XMLSchema#string

P2860

A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance

A multidrug resistance transporter from human MCF-7 breast cancer cells

The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells

Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice

Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance

Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.

P304

1084-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1041599

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BCP.2012.01.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221750885

http://www.w3.org/2001/XMLSchema#string

P698

22248732

http://www.w3.org/2001/XMLSchema#string

P932

3307098

http://www.w3.org/2001/XMLSchema#string